Emily Hacker, MPH; Kailynn Mitchell, MPH; Caroline Mohr, MPH
WMJ. 2025;124(5):460-462.
ABSTRACT
Background: Justice-involved individuals are disproportionately affected by hepatitis C virus (HCV) infection. Wisconsin’s viral hepatitis elimination plan prioritizes this population, yet little is known about jail capacity for testing and treatment.
Methods: A 10-item survey was emailed to administrators of 71 county jails and 1 Tribal detention facility to assess HCV testing and treatment practices and barriers. Responses were analyzed descriptively.
Results: Thirty facilities (41.7%) responded. Ten jails (33.3%) offered HCV testing; 15 (51.7%) provided treatment. Common barriers to testing included lack of contracted services (40%) and staffing constraints (23.3%). Barriers to treatment included financial restrictions (66.7%) and short incarceration periods (33.3%).
Discussion: Limited testing and treatment capacity persists despite Medicaid coverage and effective therapies.
Conclusions: Partnerships with local health agencies and policy changes addressing cost and contractual limitations are essential to expand HCV services in Wisconsin jails.